Citation: | Wei Geng, Fansheng Kong, Huanhuan Gao, Hongjin Chang, Jiahui Wang, Na Zhang, Dongqing Han, Yan Zhao. The HLA Epitope Donor Database for Platelet Matching[J]. Blood&Genomics, 2024, 8(1): 10003. DOI: 10.70322/BG20240110003 |
[1] |
. Wu G, Zhou Y, Li L, Zhong Z, Li H, Li H, et al. Platelet Immunology in China: Research and Clinical Applications. Transfus. Med. Rev. 2017, 31, 118–125.
|
[2] |
. Chen XW, Yu XF, Tian ZS. Transfusion Therapeutics; Science Press: Beijing, China, 2012; pp. 134–141.
|
[3] |
. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, et al. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 2001, 19, 1519–1538.
|
[4] |
. Brown CJ, Navarrete CV. Clinical relevance of the HLA system in blood transfusion. Vox Sang. 2011, 101, 93–105.
|
[5] |
. Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000, 40, 1446–1456.
|
[6] |
. Brand A, van Leeuwen A, Eernisse JG, van Rood JJ. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood 1978, 51, 781–788.
|
[7] |
. Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet refractoriness–practical approaches and ongoing dilemmas in patient management. Br. J. Haematol. 2015, 171, 297–305.
|
[8] |
. Zhao TM, Hong JL, Liu JH, Gao DY, Liu Q, Du D, et al. Probability of finding HLA-matched unrelated marrow donor from Chinese Marrow Donor Program. Chin. J. Blood Transfus. 2013, 26, 506–510.
|
[9] |
. Vassallo RR. Changing paradigms in matched platelet support. Transfusion 2008, 48, 204–206.
|
[10] |
. Duquesnoy RJ. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: A new strategy to provide more ef fective platelet transfusion support? Transfusion. 2008, 48, 221–227.
|
[11] |
. Duquesnoy RJ, Marrari M. HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum. Immunol. 2002, 63, 353–363.
|
[12] |
. Duquesnoy RJ, Howe J, Takemoto S. HLAmatchmaker: A molecularly based algo rithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation 2003, 75, 889–897.
|
[13] |
. Tambur AR, Claas FH. HLA epitopes as viewed by antibodies: What is it all about? Am. J. Transplant. 2015, 15, 1148–1154.
|
[14] |
. Kallon D, Navarrete CV, Sage DA, Stanworth S, Mufti GJ, Marsh JCW, et al. Impact of Human Leucocyte Antigen epitope matched platelet transfusions in alloimmunised aplastic anaemia patients. Transfus. Med. 2020, 30, 23–29.
|
[15] |
. Marsh JC, Stanworth SJ, Pankhurst LA, Kallon D, Gilbertson AZ, Pigden C, et al. An epitope-based approach of HLA-matched platelets for transfusion: A noninferiority crossover randomized trial. Blood 2021, 137, 310–322.
|
[16] |
. Tambur AR. HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details. Front. Immunol. 2018, 9, 2010.
|
[17] |
. Lemieux W, Mohammadhassanzadeh H, Klement W, Daniel C, Sapir-Pichhadze R. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation. Int. J. Immunogenet. 2021, 48, 135–144.
|
[18] |
. Zhao TM. The formula for estimating the probability of finding HLA-Matched unrelated marrow donor and its application. Chin. J. Blood Transfus. 2003, 16, 381–384.
|
[19] |
. Yu M, Li LL, Li HC, Lu F, Pei YF, Huang HN, et al. The design and establishment of the platelet donor database with known HLA/HPA genotype in Nanning area. Chin. J. Blood Transfus. 2018, 31, 1265–1270.
|
[20] |
. Excoffier L, Lischer HE. Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Mol. Ecol. Resour. 2010, 10, 564–567.
|
[21] |
. Forest SK, Hod EA. Management of the Platelet Refractory Patient. Hematol Oncol Clin North Am. 2016, 30, 665–667.
|
[22] |
. Wu GG, Shen WD. Reflections on the construction of platelet immunology in China. Chin. J. Blood Transfus. 2014, 27, 5–7.
|
[23] |
. Wu GG. Detection of clinically relevant platelet antibodies in the Asian population. ISBT Sci. Ser. 2014, 9, 112–117.
|
[24] |
. Qi J, Li YH, Wang TJ, Li FQ, Wu JH, Shang LX, et al. The capacity evaluation and utilization strategy of the platelet donor database with known HLA/HPA genotype in Shaanxi. Chin. J. Blood Transfus. 2022, 35, 799–804.
|